These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27775802)

  • 1. Expression of lncRNA HULC in cervical cancer and its correlation with tumor progression and patient survival.
    Wang YF; Zhang S; Li XQ; Wang Y
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3987-3991. PubMed ID: 27775802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of long non-coding RNA LET inhibits carcinogenesis of cervical cancer.
    Jiang S; Wang HL; Yang J
    Int J Clin Exp Pathol; 2015; 8(1):806-11. PubMed ID: 25755778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Expression Levels of Long Non-Coding RNA, Loc554202, Are Predictive of Poor Prognosis in Cervical Cancer.
    Chen J; Zhu J
    Tohoku J Exp Med; 2017 Nov; 243(3):165-172. PubMed ID: 29129878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer.
    Jin C; Shi W; Wang F; Shen X; Qi J; Cong H; Yuan J; Shi L; Zhu B; Luo X; Zhang Y; Ju S
    Oncotarget; 2016 Aug; 7(32):51763-51772. PubMed ID: 27322075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
    Cao S; Liu W; Li F; Zhao W; Qin C
    Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer.
    Peng W; Gao W; Feng J
    Med Oncol; 2014 Dec; 31(12):346. PubMed ID: 25412939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
    Chen X; Liu L; Zhu W
    Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CCHE1 overexpression predicts a poor prognosis for cervical cancer.
    Chen Y; Wang CX; Sun XX; Wang C; Liu TF; Wang DJ
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):479-483. PubMed ID: 28239824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer.
    Huang L; Liao LM; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M
    Arch Gynecol Obstet; 2014 Oct; 290(4):717-23. PubMed ID: 24748337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
    Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC
    Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical important dysregulation of long non-coding RNA CCHE1 and HULC in carcinogenesis of cervical cancer.
    Naghashi N; Ghorbian S
    Mol Biol Rep; 2019 Oct; 46(5):5419-5424. PubMed ID: 31364021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer.
    Cao W; Peng T; Zhou Y
    J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer.
    Huang HW; Xie H; Ma X; Zhao F; Gao Y
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4529-4535. PubMed ID: 29131264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients.
    Uzan VR; Lengert Av; Boldrini É; Penna V; Scapulatempo-Neto C; Scrideli CA; Filho AP; Cavalcante CE; de Oliveira CZ; Lopes LF; Vidal DO
    PLoS One; 2016; 11(6):e0156774. PubMed ID: 27253450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer.
    Zhang HH; Li AH
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3357-3362. PubMed ID: 29917186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
    Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
    Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.